Case study 2 Georgia is an intensive care unit nurse with twenty years’ experience in caring for critically injured patients. She is training Moshe, a new nurse fresh from graduate school. One day, as he is returning from lunch, he sees Georgia leaving the room of one of his patients. This pattern repeats over the course of the next month. On one of these occasions, he questions Georgia as to the patient’s condition. Georgia replies that the patient was in pain and needed a bolus dose of fentanyl. The next day, when Moshe sees Georgia leaving his patient’s room, he inspects the fentanyl drip and sees that it has more volume than when he left on break earlier. He further learns that patients on fentanyl drips on this floor have been showing signs of inadequate analgesia. Subsequent investigation shows that the fentanyl drips have been diluted. 1. What is Moshe’s responsibility in this scenario? _______________________________________________________________________________________________ _______________________________________________________________________________________________ 2. How might the management of the facility respond? _______________________________________________________________________________________________ _______________________________________________________________________________________________ 3. What steps might be taken to safeguard the integrity of patient treatment? _______________________________________________________________________________________________ _______________________________________________________________________________________________
CONCLUSIONS
This activity summarizes the regulatory framework and clinical recommendations necessary to prescribe CS safely. Knowledge of best practices must be accompanied by clinical implementation to ensure appropriate treatment of patients commonly treated with CS for a variety of medical indications. Key precautions in prescribing CS include selecting appropriate candidates based on their medical condition and degree of risk, following evidence-based protocols for treatment, and recognizing problematic or dangerous use patterns that call for intervention. This includes recognizing the value of evidence-based medications for OUD.
It is imperative that HCPs keep current with changing federal, state, and local requirements, to prescribe the lowest effective doses of CS used with a variety of medical conditions, to monitor patients for any ill effects, and to help safeguard society from the dangers brought by the misuse and diversion of these powerful drugs.
WORKS CITED https://qr2.mobi/TN-guidelines
Page 22
Book Code: TN24CME
Powered by FlippingBook